✦ LIBER ✦

P28 – 2016 Cognitive and behavioural study of 24 consecutive patients with a Dravet syndrome

✍ Scribed by Villeneuve, N; Laguitton, V; Viellard, M; Lepine, A; Chabrol, B; Dravet, C; Milh, M

Book ID: 123115837
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 82 KB
Volume: 17
Category: Article
ISSN: 1090-3798
DOI: 10.1016/S1090-3798(13)70207-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive and adaptive evaluation of 21

Cognitive and adaptive evaluation of 21 consecutive patients with Dravet syndrome

✍ Villeneuve, Nathalie; Laguitton, Virginie; Viellard, Marine; Lépine, Anne; Chabr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 277 KB

P185 Long-term cognitive and behavioural

P185 Long-term cognitive and behavioural follow-up of patients with Dravet syndrome

✍ K. Van Hasselt; A. Fonteyne; F. Roelens; L. Dom; I. Van Ingelghem; R. Van Coster 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

A randomized comparison of group cogniti

A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months

✍ A. Bechdolf; D. Köhn; B. Knost; R. Pukrop; J. Klosterkötter 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Health-related quality of life in patien

✍ Montserrat Núñez; Joaquim Fernández-Solà; Esther Nuñez; José-Manuel Fernández-Hu 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

The effects of using cognitive behaviour

The effects of using cognitive behavioural therapy to improve sleep for patients with delusions and hallucinations (the BEST study): study protocol for a randomized controlled trial

✍ Daniel Freeman, Helen Startup, Elissa Myers, Allison Harvey, John Geddes… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 227 KB

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This